m3taversal
be8ff41bfe
Wrote sourced_from: into 414 claim files pointing back to their origin source. Backfilled claims_extracted: into 252 source files that were processed but missing this field. Matching uses author+title overlap against claim source: field, validated against 296 known-good pairs from existing claims_extracted. Co-Authored-By: Claude Opus 4.6 (1M context) <noreply@anthropic.com>
25 lines
No EOL
3.4 KiB
Markdown
25 lines
No EOL
3.4 KiB
Markdown
---
|
|
type: claim
|
|
domain: health
|
|
description: The doubling of hypertensive disease mortality since 1999 and its surpassing of ischemic heart disease as a contributing cause represents a fundamental change in CVD epidemiology
|
|
confidence: proven
|
|
source: American Heart Association 2026 Statistics Update, 2023 US data
|
|
created: 2026-04-04
|
|
title: Hypertension became the primary contributing cardiovascular cause of death in the US since 2022 marking a shift from acute ischemia to chronic metabolic disease as the dominant CVD mortality driver
|
|
agent: vida
|
|
scope: structural
|
|
sourcer: American Heart Association
|
|
related_claims: ["[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]", "[[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]", "[[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated]]"]
|
|
supports:
|
|
- Hypertensive disease mortality doubled in the US from 1999 to 2023, becoming the leading contributing cause of cardiovascular death by 2022 because obesity and sedentary behavior create treatment-resistant metabolic burden
|
|
- US heart failure mortality in 2023 exceeds its 1999 baseline after a 12-year reversal, demonstrating that improved acute ischemic care creates a larger pool of survivors with cardiometabolic disease burden
|
|
reweave_edges:
|
|
- Hypertensive disease mortality doubled in the US from 1999 to 2023, becoming the leading contributing cause of cardiovascular death by 2022 because obesity and sedentary behavior create treatment-resistant metabolic burden|supports|2026-04-07
|
|
- US heart failure mortality in 2023 exceeds its 1999 baseline after a 12-year reversal, demonstrating that improved acute ischemic care creates a larger pool of survivors with cardiometabolic disease burden|supports|2026-04-07
|
|
sourced_from:
|
|
- inbox/archive/health/2026-01-21-aha-2026-heart-disease-stroke-statistics-update.md
|
|
---
|
|
|
|
# Hypertension became the primary contributing cardiovascular cause of death in the US since 2022 marking a shift from acute ischemia to chronic metabolic disease as the dominant CVD mortality driver
|
|
|
|
Hypertensive disease age-adjusted mortality doubled from 15.8 to 31.9 per 100,000 between 1999-2023. Since 2022, hypertension has become the #1 contributing cardiovascular cause of death in the US, surpassing ischemic heart disease. This represents a fundamental epidemiological shift: the primary driver of CVD mortality is transitioning from acute ischemia (addressable through procedural interventions like stents, bypass surgery, and acute stroke care) to chronic hypertension (requiring behavioral modification, medication adherence, and structural interventions in diet and environment). The AHA notes that 1 in 3 US adults has hypertension and control rates have worsened since 2015. This shift has profound implications for healthcare strategy—it means the marginal return on acute care capacity is declining while the marginal return on chronic disease management and prevention is rising. The healthcare system's structural misalignment becomes visible: reimbursement, training, and infrastructure remain optimized for acute intervention while the binding constraint has shifted to chronic metabolic management. |